ResearcherTohoku UniversityActive in the last 2 years
Shin Miura
Matched on ORCID iD 0000-0002-9561-0754; OpenAlex author ID A5084797634. Sources: OpenAlex.
Their work
- Papers
- 10
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 24
2013: 2 papers · 2014: 2 papers · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: 2 papers · 2021: 1 paper · 2022: 1 paper · 2023: 1 paper · 2024: none · 2025: none · 2026: 1 paper
Papers 10
- Utility of longitudinal changes in CA19-9 for detection of pancreatic ductal adenocarcinoma in patients with benign pancreatic diseases. Co-author DOI 10.1016/j.pan.2026.10.007↗
- GATA6 and CK5 Stratify the Survival of Patients With Pancreatic Cancer Undergoing Neoadjuvant Chemotherapy. Co-author DOI 10.1016/j.modpat.2023.100102↗
- Clinical features and prognostic impact of asymptomatic pancreatic cancer. Co-author DOI 10.1038/s41598-022-08083-6↗
- Focal Parenchymal Atrophy of the Pancreas Is Frequently Observed on Pre-Diagnostic Computed Tomography in Patients with Pancreatic Cancer: A Case-Control Study. Co-author DOI 10.3390/diagnostics11091693↗
- New-Onset or Exacerbation of Diabetes Mellitus Is a Clue to the Early Diagnosis of Pancreatic Cancer. Co-author DOI 10.1620/tjem.252.353↗
- Focal Parenchymal Atrophy and Fat Replacement Are Clues for Early Diagnosis of Pancreatic Cancer with Abnormalities of the Main Pancreatic Duct. Co-author DOI 10.1620/tjem.252.63↗
- MiR-365 induces gemcitabine resistance in pancreatic cancer cells by targeting the adaptor protein SHC1 and pro-apoptotic regulator BAX. Co-author DOI 10.1016/j.cellsig.2013.11.003↗
- CUB-domain containing protein 1 represses the epithelial phenotype of pancreatic cancer cells. Co-author DOI 10.1016/j.yexcr.2013.12.019↗
- miR-197 induces epithelial-mesenchymal transition in pancreatic cancer cells by targeting p120 catenin. Co-author DOI 10.1002/jcp.24280↗
- The angiotensin II type I receptor blocker olmesartan inhibits the growth of pancreatic cancer by targeting stellate cell activities in mice. Co-author DOI 10.3109/00365521.2013.777776↗
Closest collaborators
The 24 strongest of 24 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Atsushi Masamune · 10 shared papers, 2013–2026 · strength 1.00
- Paper Utility of longitudinal changes in CA19-9 for detection of pancreatic ductal adenocarcinoma in patients with benign pan… DOI 10.1016/j.pan.2026.10.007↗
- Paper GATA6 and CK5 Stratify the Survival of Patients With Pancreatic Cancer Undergoing Neoadjuvant Chemotherapy. DOI 10.1016/j.modpat.2023.100102↗
- Paper Clinical features and prognostic impact of asymptomatic pancreatic cancer. DOI 10.1038/s41598-022-08083-6↗
- Shin Hamada · 9 shared papers, 2013–2026 · strength 0.85
- Paper Utility of longitudinal changes in CA19-9 for detection of pancreatic ductal adenocarcinoma in patients with benign pan… DOI 10.1016/j.pan.2026.10.007↗
- Paper Clinical features and prognostic impact of asymptomatic pancreatic cancer. DOI 10.1038/s41598-022-08083-6↗
- Paper Focal Parenchymal Atrophy of the Pancreas Is Frequently Observed on Pre-Diagnostic Computed Tomography in Patients with… DOI 10.3390/diagnostics11091693↗
- Kazuhiro Kikuta · 7 shared papers, 2013–2026 · strength 0.74
- Paper Utility of longitudinal changes in CA19-9 for detection of pancreatic ductal adenocarcinoma in patients with benign pan… DOI 10.1016/j.pan.2026.10.007↗
- Paper Clinical features and prognostic impact of asymptomatic pancreatic cancer. DOI 10.1038/s41598-022-08083-6↗
- Paper Focal Parenchymal Atrophy of the Pancreas Is Frequently Observed on Pre-Diagnostic Computed Tomography in Patients with… DOI 10.3390/diagnostics11091693↗
- Michiaki Unno · 6 shared papers, 2013–2026 · strength 0.74
- Paper Utility of longitudinal changes in CA19-9 for detection of pancreatic ductal adenocarcinoma in patients with benign pan… DOI 10.1016/j.pan.2026.10.007↗
- Paper GATA6 and CK5 Stratify the Survival of Patients With Pancreatic Cancer Undergoing Neoadjuvant Chemotherapy. DOI 10.1016/j.modpat.2023.100102↗
- Paper Clinical features and prognostic impact of asymptomatic pancreatic cancer. DOI 10.1038/s41598-022-08083-6↗
- Tetsuya Takikawa · 6 shared papers, 2013–2026 · strength 0.71
- Paper Utility of longitudinal changes in CA19-9 for detection of pancreatic ductal adenocarcinoma in patients with benign pan… DOI 10.1016/j.pan.2026.10.007↗
- Paper Clinical features and prognostic impact of asymptomatic pancreatic cancer. DOI 10.1038/s41598-022-08083-6↗
- Paper Focal Parenchymal Atrophy of the Pancreas Is Frequently Observed on Pre-Diagnostic Computed Tomography in Patients with… DOI 10.3390/diagnostics11091693↗
- Ryotaro Matsumoto · 5 shared papers, 2020–2026 · strength 0.67
- Paper Utility of longitudinal changes in CA19-9 for detection of pancreatic ductal adenocarcinoma in patients with benign pan… DOI 10.1016/j.pan.2026.10.007↗
- Paper Clinical features and prognostic impact of asymptomatic pancreatic cancer. DOI 10.1038/s41598-022-08083-6↗
- Paper Focal Parenchymal Atrophy of the Pancreas Is Frequently Observed on Pre-Diagnostic Computed Tomography in Patients with… DOI 10.3390/diagnostics11091693↗
- Naoki Yoshida · 4 shared papers, 2020–2022 · strength 0.44
- Paper Clinical features and prognostic impact of asymptomatic pancreatic cancer. DOI 10.1038/s41598-022-08083-6↗
- Paper Focal Parenchymal Atrophy of the Pancreas Is Frequently Observed on Pre-Diagnostic Computed Tomography in Patients with… DOI 10.3390/diagnostics11091693↗
- Paper New-Onset or Exacerbation of Diabetes Mellitus Is a Clue to the Early Diagnosis of Pancreatic Cancer. DOI 10.1620/tjem.252.353↗
- Kei Nakagawa · 2 shared papers, 2022–2023 · strength 0.29
- Toru Furukawa · 2 shared papers, 2020–2023 · strength 0.25
- Fumiya Kataoka · 2 shared papers, 2021–2022 · strength 0.25
- Shuichi Aoki · 1 shared paper, 2026 · strength 0.23
- Toshiaki Abe · 1 shared paper, 2026 · strength 0.23
- Masahiro Iseki · 2 shared papers, 2020 · strength 0.19
- Tooru Shimosegawa · 4 shared papers, 2013–2014 · strength 0.18
- Paper MiR-365 induces gemcitabine resistance in pancreatic cancer cells by targeting the adaptor protein SHC1 and pro-apoptot… DOI 10.1016/j.cellsig.2013.11.003↗
- Paper CUB-domain containing protein 1 represses the epithelial phenotype of pancreatic cancer cells. DOI 10.1016/j.yexcr.2013.12.019↗
- Paper The angiotensin II type I receptor blocker olmesartan inhibits the growth of pancreatic cancer by targeting stellate ce… DOI 10.3109/00365521.2013.777776↗
- Takashi Kokumai · 1 shared paper, 2023 · strength 0.15
- Masamichi Mizuma · 1 shared paper, 2023 · strength 0.15
- Takanori Morikawa · 1 shared paper, 2023 · strength 0.15
- Yuko Omori · 1 shared paper, 2023 · strength 0.15
- Yusuke Mizukami · 1 shared paper, 2023 · strength 0.15
- Kennichi Satoh · 3 shared papers, 2013–2014 · strength 0.14
- Paper MiR-365 induces gemcitabine resistance in pancreatic cancer cells by targeting the adaptor protein SHC1 and pro-apoptot… DOI 10.1016/j.cellsig.2013.11.003↗
- Paper CUB-domain containing protein 1 represses the epithelial phenotype of pancreatic cancer cells. DOI 10.1016/j.yexcr.2013.12.019↗
- Paper miR-197 induces epithelial-mesenchymal transition in pancreatic cancer cells by targeting p120 catenin. DOI 10.1002/jcp.24280↗
- Jun Unno · 1 shared paper, 2013 · strength 0.03
- Atsushi Kanno · 1 shared paper, 2013 · strength 0.03
- Shinichi Egawa · 1 shared paper, 2013 · strength 0.03
- Fuyuhiko Motoi · 1 shared paper, 2013 · strength 0.03
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.